If retail buying cyclical, do you have to . And one of the potential movers u. S. , theket in the pharmaceutical analysts. A lot of pockets but we can start in the u. S. What is your biggest take away and how should the markets be taking it . I think the simple read of trying to analyze wave one, wave two, it really does not matter. At how thisto look rise in the number of cases, i think we talked about this last week, actually translates. Nobody wants to get infections running around still but we want to make sure that people, if they are getting hospitalized, that that is the hardest and best number to practice with. It is possible that because you are doing thousands more tests, you are obviously finding more infected people. Lets just keep an eye on the hospitalization rate. That is the one i am keen to look at. And it is not as well reported for some reason. So what is it telling us . I get what you are saying about the fact we are testing more and logically, therefore, the number